Epidemiological evidence has linked the development and progression of several
cancers including
melanoma with
obesity. However, whether
obesity impinges on responses of
cancer cells to treatment remains less understood. Here we report that human adipocytes contribute to resistance of
melanoma cells to various therapeutic agents. Exposure to media from adipocyte cultures (adipocyte media) increased cell proliferation and reduced sensitivity of
melanoma cells to apoptosis induced by diverse chemotherapeutic drugs, including the
DNA-damaging
drug cisplatin, the microtubuletargeting agent
docetaxel, and the
histone deacetylase inhibitor SAHA. This was associated with increased activation of PI3K/Akt and
MEK/ERK signaling, and was attenuated by a PI3K or
MEK inhibitor. The effect of adipocyte media on
melanoma cells was, at least in part, due to the interaction between the
adipokine leptin and its long form
receptor OB-Rb, in that immunodepletion of
leptin in adipocyte media or
siRNA knockdown of OB-Rb in
melanoma cells reversed the increase in Akt and ERK activation, enhancement in cell proliferation, and importantly, protection of
melanoma cells against the drugs. In support, recombinant
leptin partially recapitulated the effect of adipocyte media on
melanoma cells. Of note, OB-Rb was increased on the surface of
melanoma cells compared to melanocytes, whereas
leptin short form receptors appeared to be suppressed post-transcriptionally, suggesting that OB-Rb was selectively upregulated in
melanoma cells. Collectively, these results indicate that adipocytes contribute to the resistance of
melanoma cells to chemotherapeutic drugs and agents targeting the PI3K/Akt and MEK/ERK pathways, and suggest that inhibition of the
leptin/ OB-Rb system may be useful to improve the efficacy of multiple therapeutic approaches in the treatment of
melanoma.